These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 22465937)
1. Metabolism of bilirubin by human cytochrome P450 2A6. Abu-Bakar A; Arthur DM; Wikman AS; Rahnasto M; Juvonen RO; Vepsäläinen J; Raunio H; Ng JC; Lang MA Toxicol Appl Pharmacol; 2012 May; 261(1):50-8. PubMed ID: 22465937 [TBL] [Abstract][Full Text] [Related]
2. Inducible bilirubin oxidase: a novel function for the mouse cytochrome P450 2A5. Abu-Bakar A; Arthur DM; Aganovic S; Ng JC; Lang MA Toxicol Appl Pharmacol; 2011 Nov; 257(1):14-22. PubMed ID: 21871474 [TBL] [Abstract][Full Text] [Related]
3. Evidence for induced microsomal bilirubin degradation by cytochrome P450 2A5. Abu-Bakar A; Moore MR; Lang MA Biochem Pharmacol; 2005 Nov; 70(10):1527-35. PubMed ID: 16183037 [TBL] [Abstract][Full Text] [Related]
4. Mechanism-based inhibition of cytochrome P450 (CYP)2A6 by chalepensin in recombinant systems, in human liver microsomes and in mice in vivo. Ueng YF; Chen CC; Chung YT; Liu TY; Chang YP; Lo WS; Murayama N; Yamazaki H; Souček P; Chau GY; Chi CW; Chen RM; Li DT Br J Pharmacol; 2011 Jul; 163(6):1250-62. PubMed ID: 21418183 [TBL] [Abstract][Full Text] [Related]
5. Interaction of aflatoxin B1 with cytochrome P450 2A5 and its mutants: correlation with metabolic activation and toxicity. Pelkonen P; Lang MA; Negishi M; Wild CP; Juvonen RO Chem Res Toxicol; 1997 Jan; 10(1):85-90. PubMed ID: 9074807 [TBL] [Abstract][Full Text] [Related]
6. Function and regulation of the Cyp2a5/CYP2A6 genes in response to toxic insults in the liver. Abu-Bakar A; Hakkola J; Juvonen R; Rahnasto-Rilla M; Raunio H; Lang MA Curr Drug Metab; 2013 Jan; 14(1):137-50. PubMed ID: 22497566 [TBL] [Abstract][Full Text] [Related]
7. Involvement of CYP2A6 in the formation of a novel metabolite, 3-hydroxypilocarpine, from pilocarpine in human liver microsomes. Endo T; Ban M; Hirata K; Yamamoto A; Hara Y; Momose Y Drug Metab Dispos; 2007 Mar; 35(3):476-83. PubMed ID: 17178767 [TBL] [Abstract][Full Text] [Related]
8. Contribution of CYP2C9, CYP2A6, and CYP2B6 to valproic acid metabolism in hepatic microsomes from individuals with the CYP2C9*1/*1 genotype. Kiang TK; Ho PC; Anari MR; Tong V; Abbott FS; Chang TK Toxicol Sci; 2006 Dec; 94(2):261-71. PubMed ID: 16945988 [TBL] [Abstract][Full Text] [Related]
9. Human cytochrome P450 isozymes in metabolism and health effects of gasoline ethers. Hong JY; Wang YY; Mohr SN; Bondoc FY; Deng C Res Rep Health Eff Inst; 2001 May; (102):7-27; discussion 95-109. PubMed ID: 11504148 [TBL] [Abstract][Full Text] [Related]
10. Expression of cytochrome P450 2A6 in Escherichia coli: purification, spectral and catalytic characterization, and preparation of polyclonal antibodies. Soucek P Arch Biochem Biophys; 1999 Oct; 370(2):190-200. PubMed ID: 10510277 [TBL] [Abstract][Full Text] [Related]
11. Metabolism of 7-ethoxycoumarin, safrole, flavanone and hydroxyflavanone by cytochrome P450 2A6 variants. Uno T; Obe Y; Ogura C; Goto T; Yamamoto K; Nakamura M; Kanamaru K; Yamagata H; Imaishi H Biopharm Drug Dispos; 2013 Mar; 34(2):87-97. PubMed ID: 23112005 [TBL] [Abstract][Full Text] [Related]
12. Characterization of inhibitory effects of perfluorooctane sulfonate on human hepatic cytochrome P450 isoenzymes: focusing on CYP2A6. Narimatsu S; Nakanishi R; Hanioka N; Saito K; Kataoka H Chem Biol Interact; 2011 Nov; 194(2-3):120-6. PubMed ID: 21964418 [TBL] [Abstract][Full Text] [Related]
13. An inhibitory monoclonal antibody to human cytochrome P450 2A6 defines its role in the metabolism of coumarin, 7-ethoxycoumarin and 4-nitroanisole in human liver. Sai Y; Yang TJ; Krausz KW; Gonzalez FJ; Gelboin HV Pharmacogenetics; 1999 Apr; 9(2):229-37. PubMed ID: 10376770 [TBL] [Abstract][Full Text] [Related]
14. (+)-cis-3,5-dimethyl-2-(3-pyridyl) thiazolidin-4-one hydrochloride (SM-12502) as a novel substrate for cytochrome P450 2A6 in human liver microsomes. Nunoya K; Yokoi Y; Kimura K; Kodama T; Funayama M; Inoue K; Nagashima K; Funae Y; Shimada N; Green C; Kamataki T J Pharmacol Exp Ther; 1996 May; 277(2):768-74. PubMed ID: 8627557 [TBL] [Abstract][Full Text] [Related]
15. Identification of Val117 and Arg372 as critical amino acid residues for the activity difference between human CYP2A6 and CYP2A13 in coumarin 7-hydroxylation. He XY; Shen J; Hu WY; Ding X; Lu AY; Hong JY Arch Biochem Biophys; 2004 Jul; 427(2):143-53. PubMed ID: 15196988 [TBL] [Abstract][Full Text] [Related]
16. Tumour suppressor protein p53 regulates the stress activated bilirubin oxidase cytochrome P450 2A6. Hu H; Yu T; Arpiainen S; Lang MA; Hakkola J; Abu-Bakar A Toxicol Appl Pharmacol; 2015 Nov; 289(1):30-9. PubMed ID: 26343999 [TBL] [Abstract][Full Text] [Related]
17. Characterization of CYP2A6 involved in 3'-hydroxylation of cotinine in human liver microsomes. Nakajima M; Yamamoto T; Nunoya K; Yokoi T; Nagashima K; Inoue K; Funae Y; Shimada N; Kamataki T; Kuroiwa Y J Pharmacol Exp Ther; 1996 May; 277(2):1010-5. PubMed ID: 8627511 [TBL] [Abstract][Full Text] [Related]
18. Mechanism-based inactivation of cytochrome P450 2A6 by decursinol angelate isolated from Angelica Gigas. Yoo HH; Lee MW; Kim YC; Yun CH; Kim DH Drug Metab Dispos; 2007 Oct; 35(10):1759-65. PubMed ID: 17620343 [TBL] [Abstract][Full Text] [Related]
19. Cytochrome P450 2A5 and bilirubin: mechanisms of gene regulation and cytoprotection. Kim SD; Antenos M; Squires EJ; Kirby GM Toxicol Appl Pharmacol; 2013 Jul; 270(2):129-38. PubMed ID: 23628428 [TBL] [Abstract][Full Text] [Related]
20. Estrogen-Estrogen Receptor α Signaling Facilitates Bilirubin Metabolism in Regenerating Liver Through Regulating Cytochrome P450 2A6 Expression. Kao TL; Chen YL; Kuan YP; Chang WC; Ho YC; Yeh S; Jeng LB; Ma WL Cell Transplant; 2017 Nov; 26(11):1822-1829. PubMed ID: 29338386 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]